|
|
Volumn 6 Suppl 1, Issue , 2006, Pages
|
|
Beyond imatinib: second generation c-KIT inhibitors for the management of gastrointestinal stromal tumors.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4 METHYL N (3 (4 METHYLIMIDAZOL 1 YL) 5 (TRIFLUOROMETHYL)PHENYL) 3 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YL)AMINO)BENZAMIDE;
4-METHYL-N-(3-(4-METHYLIMIDAZOL-1-YL)-5-(TRIFLUOROMETHYL)PHENYL)-3-((4-PYRIDIN-3-YLPYRIMIDIN-2-YL)AMINO)BENZAMIDE;
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
DASATINIB;
DRUG DERIVATIVE;
EVEROLIMUS;
IMATINIB;
IMMUNOSUPPRESSIVE AGENT;
INDOLE DERIVATIVE;
MIDOSTAURIN;
MONOCLONAL ANTIBODY;
N (3,3 DIMETHYL 6 INDOLINYL) 2 (4 PYRIDINYLMETHYLAMINO)NICOTINAMIDE;
NICOTINAMIDE;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
PYRROLE DERIVATIVE;
RAPAMYCIN;
STAUROSPORINE;
STEM CELL FACTOR RECEPTOR;
SUNITINIB;
THIAZOLE DERIVATIVE;
UNCLASSIFIED DRUG;
CLINICAL TRIAL;
DRUG EFFECT;
DRUG RESISTANCE;
GASTROINTESTINAL STROMAL TUMOR;
HUMAN;
REVIEW;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
DRUG RESISTANCE, NEOPLASM;
GASTROINTESTINAL STROMAL TUMORS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INDOLES;
NIACINAMIDE;
PIPERAZINES;
PROTEIN KINASE INHIBITORS;
PROTO-ONCOGENE PROTEINS C-KIT;
PYRIMIDINES;
PYRROLES;
SIROLIMUS;
STAUROSPORINE;
THIAZOLES;
MLCS;
MLOWN;
|
|
EID: 34248512697
PISSN: 15330028
EISSN: None
Source Type: Journal
DOI: 10.3816/CCC.2006.s.005 Document Type: Article |
|
Times cited : (37)
|
|
References (44)
|
